IMPLICATIONS OF OBESITY
National
Institutes of Health Consensus Development Conference Statement
February
11-13, 1985
This
statement was originally published as:
Health
Implications of Obesity. NIH Consensus Statement 1985 Feb 11-13;
5(9):1-7.
For
making bibliographic reference to the statement in the
electronic form displayed here, it is recommended that the
following format be used:
Health
Implications of Obesity. NIH Consens Statement Online 1985 Feb
11-13 [cited year month day~; 5(9):1-7.
INTRODUCTION
Current
knowledge of human obesity has progressed beyond the simple
generalizations of the past. Formerly, obesity was considered
fully explained by the single adverse behavior of inappropriate
eating in the setting of attractive foods. The study of animal
models of obesity, biochemical alterations in man and
experimental animals, and the complex interactions of
psychosocial and cultural factors that create susceptibility to
human obesity indicate that this disease in man is complex and
deeply rooted in biologic systems. Thus, it is almost certain
that obesity has multiple causes and that there are different
types of obesity.
To
assess the health implications of obesity, new knowledge and new
epidemiologic observations have introduced a variety of
complications that must be addressed. Thus, a reassessment of
definitions and measurements of obesity is required. There is
controversy surrounding the interpretation of data showing an
association of body weight with morbidity and mortality. The
interpretations of data from different studies have been
complicated by the confounding effects of smoking behavior, the
coexistence of diseases other than obesity, and variations in
methods of data collection and followup. Because population
samples in some studies have not been representative of the U.S.
population, there have been uncertainties as to how far their
conclusions can be generalized for recommendations for dietary
advice and treatment.
There
is evidence that an increasing number of children and
adolescents are ovenweight. Even though all overweight children
will not necessarily become ovenweight adults, the increasing
prevalence of obesity in childhood is likely to be reflected in
increasing obesity in adult years. The high prevalence of
obesity in our adult population and the likelihood that the
nation of the future will be even more obese demand a
reassessment of the health implications of this condition.
For
the special purpose of resolving the pressing questions relating
to the health implications of obesity, the NIH Office of Medical
Applications of Research, the National Institute of Arthriti
Based
on indices of body fat, studies of large populations have shown
that there is a continuous
relationship
between RW or BMI and morbidity and mortality. Thus, it becomes
important to establish ranges of these indices as guidelines for
developing appropriate and effective approaches for the
treatment and prevention of obesity.
Since
the amount of body fat, as estimated by the above indices, is a
continuous variable within the population, all quantitative
definitions of obesity must be arbitrary. The panelists agree
that an increase-in body weight of 20 percent or more above
desirable body weight constitutes an established health hazard.
Significant health risks at lower levels of obesity can present
hazards, especially in the presence of diabetes, hypertension,
heart disease, or their associated risk factors.
WHAT
IS THE EVIDENCE THAT OBESITY
HAS
ADVERSE EFFECTS ON HEALTH
Clinical
observations have long suggested a connection of obesity
(particularly in its extreme forms) with a variety of illnesses.
Obesity creates an enormous psychological burden. In fact, in
terms of suffering, this burden may be the greatest adverse
effect of obesity. At the present time, the strongest evidence
that obesity has an adverse effect on physical health comes from
population-based prevalence (cross-sectional) and cohort (followup)
studies. These data are complemented by weight reduction trials.
The
most comprehensive data on prevalence of cardiovascular disease
(CVD) risk factors and obesity are the National Health and
Nutrition Examination Surveys (NHANES). NHANES I was conducted
from 1971 through 1974 and NHANES n from 1976 through 1980. Both
were based on a representative sample of residents of the United
States.
Data
from NHANES II were analyzed by comparing several parameters for
the subjects at or above, or below, the 85th percentile of the
reference population.* At or above this cutoffpoint, males have
a BS 'v7.8 and females have a BS >97.3. This analysis showed
a strong association between the prevalence of obesity and CVD
risk factors. Based on these criteria, the prevalence of
hypertension (blood pressure greater than 160/95) is 2.9 times
higher for the overweight than for the nonoverweight. The
prevalence is 5.6 times higher for the young (20 through 44
years old) overweight than for the nonoverweight subjects in
this age group. The prevalence is twice as high for the obese
older (45 through 74 years old) group as it is for the
nonoverweight subjects of the same age. The prevalence of
hypercholesterolemia (blood cholesterol over 250 mg/dl) in the
young overweight age group is 2.1 times that ofthe nonoverweight
group; overweight and nonoverweight subjects show similar
prevalences for hypercholesterolernia after age 45.
*
Noninstitutionalized, nonpregnant U.S. residents, ages 20 to 29,
197S1980.
Levels
of blood pressure and serum cholesterol vary with levels of
obesity in a continuous manner. This relationship holds for the
so-called normal as well as the elevated range in observational
studies. Intervention studies confirm that levels of blood
pressure and serum cholesterol can be reduced by weight
reduction.
The
prevalence of reported diabetes is 2.9 times higher in
overweight than nonoverweight persons in otherwise not
representative of the U.S. population. The greater the degree of
overweight, the higher the mortality ratio or excess death rate.
Both mortality ratio and excess deaths per 1,000 per year
increase with length of followup. Two small groups of insurance
policyholders who reduced weight to acceptable levels for
standard insurance had a decline in mortality to normal. In the
insurance studies, the increased mortality with overweight was
observed in normotensive men and women, without other major
impairment, who would have been eligible for standard insurance
rates except for being overweight: Smokers were not
differentiated from nonsmokers. In the Framingham and ACS
studies, the increase in excess mortality with increasing
degrees of overweight was present in both smokers and
nonsmokers.
The
pattern of excess mortality variation with relative weight is
illustrated in men ages 15 to 39 years at entry from data in the
1979 Build Study
Weight
Relative
to
Mortality
Average
Weight
Ratio
65-75*
105*
75-95
93
95-105
95
(average)
105-115
110
115-125
127
125-135
134
135-145
141
145-155
211
155-165
227
For
those with relative weight of 125 to 135 percent at entry, the
aggregate mortality ratio was 134 percent, as shown above. When
mortality was analyzed by duration, the mortality ratio
increased from 110 percent at the 0 to 5-year interval to 169
percent at the 15 to 22-year interval. The weight class for
lowest mortality shown above is below the average weight
category. There is higher mortality m the lowest relative weight
class, 65 to 75 percent of average. In extreme obesity
("morbid'2 obesity), the mortality ratio has been reported
in a small series as being of the order of 1 200 percent. A
recent analysis has shown that the body mass index of minimum
mortality, derived from the data in the 1979 Build Study,
increases with age in a straight line relationship, the lines
for male and female being virtually identical. The 1959 and 1983
Metropolitan Life Insurance Company tables of ranges of weight
with minimal mortality do not provide for any age variation.
The
increase in mortality versus relative weight is steeper in men
and women under age 50 than in older persons, and the increase
with duration is also steeper. These findings suggest that
particular attention should be paid to efforts to reduce weight
in younger patients.
Recent
studies suggest that the distribution of fat deposits may be a
better predictor of mortality than BMI or RW. If confirmed, it
may be important in the future to measure fat distribution in
addition to using height-weight tables.
WHAT
ARE THE APPROPRIATE USES AND LIMITATIONS OF EXISTING
HEIGHT-WEIGHT TABLES?
The
mortality and morbidity related risks of obesity are influenced
by concurrent risk factors such as smoking. Tables do not
provide information on body fat distribution or degree of
obesity. Frame size as used for estimation of lean (fat-free)
body mass is subjectively determined in the 1959 tables. The use
of elbow width to judge frame size, as suggested in the 1983
tables, may or may not eliminate the problem. . Age is not taken
into account.
Body Mass Index
Body weight in kilograms
BMI = (Height in meters)2
is
a simple measurement highly correlated with other estimates of
fatness. It minimizes the effect of height and is useful for
descriptive or evaluative purposes. It has the advantage of
permitting comparison of populations. The major limitation of
the BMI is that it is difficult to interpret this mathematical
index to patients and to relate it to weight that must be lost.
The
consensus panel recommends that physicians adopt this measure as
an additional factor in evaluating patients and that nomograms
be used to facilitate calculations of BS.
FOR
WHAT MEDICAL CONDITIONS CAN
WEIGHT
REDUCTION BE RECOMMENDED?
Weight
reduction may be lifesaving for patients with extreme obesity,
arbitrarily defined as weight twice the desirable weight or 45
kg (100 pounds) over desirable weight. When obesity is
accompanied by severe cardiopulmonary manifestations, as in the
Pickwickian syndrome, weight reduction should be part of the
treatment for this medical emergency.
In
view of the excess mortality and morbidity associated with
obesity (as discussed above), weight reduction should be
recommended to persons with excess body weight of 20 percent or
more above desirable weights in the Metropolitan Life insurance
Company tables (using the rnidpoint of the range for a
medium-build person). In the 1983 tables, 20 percent over
desirable weight is a higher weight than would be obtained by
the use of the 1959 tables. The maximum increase is found in
those of short stature and does not exceed 17 percent for men or
13 percent for women. Although not a specific recommendation of
the panel, use of the lower weights as goals would be advisable
in the presence of any of the complications or risk factors
summarized below. The body mass index values, which correspond
to 20 percent above desirable weight, are 27.2 and 26.9 for men
and women, respectively, using the 1983 tables and 26.4 and 25.8
for men and women, respectively, using the 1959 tables. These
values are not substantially different from the BMI values for
men and women identified with the lower cutoffpoint for
overweight as determined by the National Center for Health
Statistics27.8 and 27.3 for men and women, respectively (NHANES
II population, bare feet, no)
1.
In infancy and childhood, we must search for biological
(genetic, metabolic, or anthropometric) markers as predictors of
adult obesity. Having such predictors would permit the study of
the development of the disease, would provide a powerful
epidemiological tool, and would allow treatment to begin very
early in life.
2.
The factors that regulate the regional distribution of fat and
methods to assess the distribution must be developed. We need to
define the mechanism by which body fat distribution is
associated with adverse effects of obesity.
3.
Regulation of energy balance is complex, but many aspects have
begun to yield to investigation.
Promising
leads are:
1.
effects of the central and autonomic nervous systems and the
endocrine system.
2.
adipose tissue cellularity (in tissue culture) and metabolism.
3.
the role of various components of thermogenesis in the overall
control of energy balance.
4.
control of food intake (e.g., endogenous opioids).
5.
satiety factors (e.g., gut hormones).
6.
Studies utilizing cultural and physical measurements in several
cultures, including minority, low socioeconomic, and rapidly
changing cultures, should be conducted.
7.
The data from large CAHD cohort studies initiated 20 to 30 years
ago should be identified and archived. Archiving should be
encouraged for data obtained from ongoing and future studies.
8.
Relative risk tables that incorporate both fat distribution and
height-weight data should be
developed.
Great
advances of modern biological science as applied to obesity can
generate new information that can now be tested at the bedside.
Clinical investigation utilizing the biological advances is
timely. The best of public health sciences, including the
anthropological and sociological, should be brought into the
study of the prevention of obesity.
CONCLUSIONS
The
evidence is now overwhelming that obesity, defined as excessive
storage of energy in the form of fat, has adverse effects on
health and longevity. Obesity is clearly associated with
hypertension, hypercholesterolemia, NIDDM, and excess of certain
cancers and other medical problems. Height and weight tables
based on mortality data or the body mass index are helpful
measures to determine the presence of obesity and the need for
treatment. Thirty-four million adult Americans have a body mass
index greater than 27.8 (men) or 27.3 (women). At this level of
obesity, which is very close to a weight increase of 20 percent
above desirable, treatment is strongly advised. When diabetes,
hypertension, or a family history for these diseases is present,
treatment will lead to benefits even when lesser degrees of
obesity are present.
Obesity
research efforts should be directed toward elucidation of
biologic markers, factors regulating the regional distribution
of fat, studies of energy regulation, and studies utilizing the
techniques of anthropology, psychiatry, and the social sciences.